XT
TTRX

XTX Topco’s Turn Therapeutics TTRX Stock Holding History

XTX Topco’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.1K Sell
19,727
-5,446
-22% -$21.2K ﹤0.01% 3254
2025
Q4 		$99.2K Buy
+25,173
New +$105K ﹤0.01% 2641

Other funds holding TTRX

DI
DDFG Inc Thousand Oaks, California $464M AUM 16.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $7.29B AUM 16.22% 1-Year Est. Return

XTX Topco's TTRX Position: Q1 2026 in Review

XTX Topco reduced its Turn Therapeutics (TTRX) stake by 22% in Q1 2026, selling an estimated $21.2K and leaving 19,727 shares worth $63.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3254.

XTX Topco first reported a position in TTRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $99.2K in Q4 2025. 20 funds tracked by Wall St. Rank hold TTRX as of Q1 2026.

  • XTX Topco held 19,727 shares of Turn Therapeutics worth $63.1K as of Q1 2026.
  • XTX Topco sold 5,446 Turn Therapeutics shares in Q1 2026, an estimated $21.2K.
  • Turn Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3254 holding.
  • XTX Topco first reported a position in Turn Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • XTX Topco's Turn Therapeutics position peaked at $99.2K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Turn Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.